← Back to home

Regeneron to Supply More Ebola Treatment Doses to U.S. Under $270 Million Deal

Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources

Brief

Regeneron said Monday it extended a 2020 agreement with the federal Biomedical Advanced Research and Development…

Keep reading with NewsPlain Premium

Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.

2 sources behind this story.

About this story

We haven’t published a correction to this story.

How NewsPlain works
← Back to home